Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries

Petra Baji, Manuel García-Goñi, L. Gulácsi, Emmanouil Mentzakis, Francesco Paolucci

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: In addition to cost-effectiveness, national guidelines often include other factors in reimbursement decisions. However, weights attached to these are rarely quantified, thus decisions can depend strongly on decision-maker preferences. Objective: To explore the preferences of policymakers and healthcare professionals involved in the decision-making process for different efficiency and equity attributes of interventions and to analyse cross-country differences. Method: Discrete choice experiments (DCEs) were carried out in Austria, Hungary, and Norway with policymakers and other professionals working in the health industry (N = 153 respondents). Interventions were described in terms of different efficiency and equity attributes (severity of disease, target age of the population and willingness to subsidise others, potential number of beneficiaries, individual health benefit, and cost-effectiveness). Parameter estimates from the DCE were used to calculate the probability of choosing a healthcare intervention with different characteristics, and to rank different equity and efficiency attributes according to their importance. Results: In all three countries, cost-effectiveness, individual health benefit and severity of the disease were significant and equally important determinants of decisions. All countries show preferences for interventions targeting young and middle aged populations compared to those targeting populations over 60. However, decision-makers in Austria and Hungary show preferences more oriented to efficiency than equity, while those in Norway show equal preferences for equity and efficiency attributes. Conclusion: We find that factors other than cost-effectiveness seem to play an equally important role in decision-making. We also find evidence of cross-country differences in the weight of efficiency and equity attributes.

Original languageEnglish
JournalEuropean Journal of Health Economics
DOIs
Publication statusAccepted/In press - Aug 22 2015

Fingerprint

Decision Support Techniques
Cost-Benefit Analysis
Austria-Hungary
Insurance Benefits
Norway
Disease Attributes
Decision Making
Delivery of Health Care
Weights and Measures
Health Services Needs and Demand
Health Care Costs
Population
Industry
Reimbursement
Equity
Comparative analysis
Decision maker
European countries
Guidelines
Health

Keywords

  • Discrete choice experiment
  • Equity-efficiency trade-off
  • Priority setting
  • Reimbursement

ASJC Scopus subject areas

  • Health Policy
  • Economics, Econometrics and Finance (miscellaneous)

Cite this

Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries. / Baji, Petra; García-Goñi, Manuel; Gulácsi, L.; Mentzakis, Emmanouil; Paolucci, Francesco.

In: European Journal of Health Economics, 22.08.2015.

Research output: Contribution to journalArticle

@article{d204792dd40841b781d2e2fba7a5e861,
title = "Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries",
abstract = "Background: In addition to cost-effectiveness, national guidelines often include other factors in reimbursement decisions. However, weights attached to these are rarely quantified, thus decisions can depend strongly on decision-maker preferences. Objective: To explore the preferences of policymakers and healthcare professionals involved in the decision-making process for different efficiency and equity attributes of interventions and to analyse cross-country differences. Method: Discrete choice experiments (DCEs) were carried out in Austria, Hungary, and Norway with policymakers and other professionals working in the health industry (N = 153 respondents). Interventions were described in terms of different efficiency and equity attributes (severity of disease, target age of the population and willingness to subsidise others, potential number of beneficiaries, individual health benefit, and cost-effectiveness). Parameter estimates from the DCE were used to calculate the probability of choosing a healthcare intervention with different characteristics, and to rank different equity and efficiency attributes according to their importance. Results: In all three countries, cost-effectiveness, individual health benefit and severity of the disease were significant and equally important determinants of decisions. All countries show preferences for interventions targeting young and middle aged populations compared to those targeting populations over 60. However, decision-makers in Austria and Hungary show preferences more oriented to efficiency than equity, while those in Norway show equal preferences for equity and efficiency attributes. Conclusion: We find that factors other than cost-effectiveness seem to play an equally important role in decision-making. We also find evidence of cross-country differences in the weight of efficiency and equity attributes.",
keywords = "Discrete choice experiment, Equity-efficiency trade-off, Priority setting, Reimbursement",
author = "Petra Baji and Manuel Garc{\'i}a-Go{\~n}i and L. Gul{\'a}csi and Emmanouil Mentzakis and Francesco Paolucci",
year = "2015",
month = "8",
day = "22",
doi = "10.1007/s10198-015-0721-x",
language = "English",
journal = "European Journal of Health Economics",
issn = "1618-7598",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries

AU - Baji, Petra

AU - García-Goñi, Manuel

AU - Gulácsi, L.

AU - Mentzakis, Emmanouil

AU - Paolucci, Francesco

PY - 2015/8/22

Y1 - 2015/8/22

N2 - Background: In addition to cost-effectiveness, national guidelines often include other factors in reimbursement decisions. However, weights attached to these are rarely quantified, thus decisions can depend strongly on decision-maker preferences. Objective: To explore the preferences of policymakers and healthcare professionals involved in the decision-making process for different efficiency and equity attributes of interventions and to analyse cross-country differences. Method: Discrete choice experiments (DCEs) were carried out in Austria, Hungary, and Norway with policymakers and other professionals working in the health industry (N = 153 respondents). Interventions were described in terms of different efficiency and equity attributes (severity of disease, target age of the population and willingness to subsidise others, potential number of beneficiaries, individual health benefit, and cost-effectiveness). Parameter estimates from the DCE were used to calculate the probability of choosing a healthcare intervention with different characteristics, and to rank different equity and efficiency attributes according to their importance. Results: In all three countries, cost-effectiveness, individual health benefit and severity of the disease were significant and equally important determinants of decisions. All countries show preferences for interventions targeting young and middle aged populations compared to those targeting populations over 60. However, decision-makers in Austria and Hungary show preferences more oriented to efficiency than equity, while those in Norway show equal preferences for equity and efficiency attributes. Conclusion: We find that factors other than cost-effectiveness seem to play an equally important role in decision-making. We also find evidence of cross-country differences in the weight of efficiency and equity attributes.

AB - Background: In addition to cost-effectiveness, national guidelines often include other factors in reimbursement decisions. However, weights attached to these are rarely quantified, thus decisions can depend strongly on decision-maker preferences. Objective: To explore the preferences of policymakers and healthcare professionals involved in the decision-making process for different efficiency and equity attributes of interventions and to analyse cross-country differences. Method: Discrete choice experiments (DCEs) were carried out in Austria, Hungary, and Norway with policymakers and other professionals working in the health industry (N = 153 respondents). Interventions were described in terms of different efficiency and equity attributes (severity of disease, target age of the population and willingness to subsidise others, potential number of beneficiaries, individual health benefit, and cost-effectiveness). Parameter estimates from the DCE were used to calculate the probability of choosing a healthcare intervention with different characteristics, and to rank different equity and efficiency attributes according to their importance. Results: In all three countries, cost-effectiveness, individual health benefit and severity of the disease were significant and equally important determinants of decisions. All countries show preferences for interventions targeting young and middle aged populations compared to those targeting populations over 60. However, decision-makers in Austria and Hungary show preferences more oriented to efficiency than equity, while those in Norway show equal preferences for equity and efficiency attributes. Conclusion: We find that factors other than cost-effectiveness seem to play an equally important role in decision-making. We also find evidence of cross-country differences in the weight of efficiency and equity attributes.

KW - Discrete choice experiment

KW - Equity-efficiency trade-off

KW - Priority setting

KW - Reimbursement

UR - http://www.scopus.com/inward/record.url?scp=84939833279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939833279&partnerID=8YFLogxK

U2 - 10.1007/s10198-015-0721-x

DO - 10.1007/s10198-015-0721-x

M3 - Article

C2 - 26296623

AN - SCOPUS:84939833279

JO - European Journal of Health Economics

JF - European Journal of Health Economics

SN - 1618-7598

ER -